Video Description

In this episode of the Oncology Brothers podcast, Drs. Rohit and Rahul Gosain welcome Dr. Sarah Sammons from Dana-Farber Cancer Institute to discuss the treatment landscape for HER2-positive breast cancer. Building on their previous discussions about triple-negative breast cancer, Drs. Gosain and Sammons dive deep into the treatment algorithms for early-stage, locally advanced, and metastatic HER2-positive breast cancer. Key topics include: •⁠ ⁠Treatment paradigms for early-stage HER2-positive breast cancer, including the APT trial and considerations for neoadjuvant therapy. •⁠ ⁠The standard of care for locally advanced disease with TCHP and managing associated toxicities. •⁠ ⁠Insights into the latest data from the PATINA trial and its implications for metastatic HER2-positive patients. •⁠ ⁠Discussion on the use of T-DXd and other treatment options in the second and third-line settings, especially for patients with brain metastases. Join us for an informative conversation filled with clinical pearls and practical insights that can help guide treatment decisions in HER2-positive breast cancer. Don't forget to like, subscribe, and check out our other episodes in the treatment algorithm series! #OncologyBrothers #HER2Positive #BreastCancer #BreastCancerTreatment #CancerPodcast #DanaFarber Apple Podcast: https://podcasts.apple.com/us/podcast/how-to-treat-her2-breast-cancer-discussion-with-dr/id1653340966?i=1000693047298 Spotify: https://creators.spotify.com/pod/show/oncology-brothers/episodes/How-to-Treat-HER2-Breast-Cancer---Discussion-with-Dr--Sarah-Sammons-e2uvto5 Follow us on social media: •⁠ ⁠X/Twitter: https://twitter.com/oncbrothers •⁠ ⁠Instagram: https://www.instagram.com/oncbrothers